Skip to main content
. 2018 Nov 23;19:649. doi: 10.1186/s13063-018-3026-4

Fig. 2.

Fig. 2

Trial schema. Trial entry, randomisation and treatment. ART antiretroviral therapy, EFA early fungicidal activity, PD pharmacodynamics, PK pharmacokinetics, SAE serious adverse event